MY170185A - Composition for use in brain growth and/or cognitive and/or psychomotor development - Google Patents
Composition for use in brain growth and/or cognitive and/or psychomotor developmentInfo
- Publication number
- MY170185A MY170185A MYPI2014700417A MYPI2014700417A MY170185A MY 170185 A MY170185 A MY 170185A MY PI2014700417 A MYPI2014700417 A MY PI2014700417A MY PI2014700417 A MYPI2014700417 A MY PI2014700417A MY 170185 A MY170185 A MY 170185A
- Authority
- MY
- Malaysia
- Prior art keywords
- composition
- cognitive
- brain growth
- psychomotor development
- oligosaccharide
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 210000004556 brain Anatomy 0.000 title abstract 2
- 230000008133 cognitive development Effects 0.000 title abstract 2
- 230000008132 psychomotor development Effects 0.000 title abstract 2
- 229920001542 oligosaccharide Polymers 0.000 abstract 4
- 150000002482 oligosaccharides Chemical class 0.000 abstract 4
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 239000006041 probiotic Substances 0.000 abstract 1
- 230000000529 probiotic effect Effects 0.000 abstract 1
- 235000018291 probiotics Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Pediatric Medicine (AREA)
- Psychology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11185600 | 2011-10-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY170185A true MY170185A (en) | 2019-07-09 |
Family
ID=47019022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2014700417A MY170185A (en) | 2011-10-18 | 2012-10-12 | Composition for use in brain growth and/or cognitive and/or psychomotor development |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20140271562A1 (enExample) |
| EP (2) | EP3095331A1 (enExample) |
| CN (1) | CN103889238B (enExample) |
| AU (1) | AU2012325060B2 (enExample) |
| BR (1) | BR112014008944B1 (enExample) |
| CL (1) | CL2014000759A1 (enExample) |
| ES (1) | ES2601891T3 (enExample) |
| IN (1) | IN2014DN01468A (enExample) |
| MX (1) | MX350435B (enExample) |
| MY (1) | MY170185A (enExample) |
| PH (1) | PH12014500443A1 (enExample) |
| PL (1) | PL2775852T3 (enExample) |
| PT (1) | PT2775852T (enExample) |
| RU (1) | RU2607458C2 (enExample) |
| WO (1) | WO2013057049A1 (enExample) |
| ZA (1) | ZA201403591B (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012532195A (ja) | 2009-07-06 | 2012-12-13 | チルドレンズ ホスピタル メディカル センター | 乳オリゴ糖による炎症の阻害 |
| DK2708147T3 (da) | 2012-09-14 | 2020-05-18 | Abbott Lab | Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose |
| EP2708145B1 (en) | 2012-09-14 | 2016-05-04 | Abbott Laboratories | Nutritional compositions for use in methods for modulating corticosterone levels in psychologically stressed individuals |
| EP2880993A1 (en) * | 2013-12-04 | 2015-06-10 | Abbott Laboratories | Method of achieving memory and learning improvement by the administration of sialic acid |
| US20170000810A1 (en) * | 2013-12-19 | 2017-01-05 | Nestec S.A. | Nutritional composition to reduce metabolic stress in infants |
| US20150305385A1 (en) * | 2014-04-25 | 2015-10-29 | Mead Johnson Nutrition Company | Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics |
| FR3020949B1 (fr) * | 2014-05-16 | 2018-02-09 | Ecole Normale Superieure De Lyon | Composition permettant de favoriser la croissance juvenile humaine et animale en cas de malnutrition |
| MY182925A (en) | 2014-10-31 | 2021-02-05 | Nestle Sa | Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition |
| WO2016086151A1 (en) * | 2014-11-26 | 2016-06-02 | Abbott Laboratories | Infant formula with rrr-alpha-tocopherol, 2'-fucosyllactose, and a probiotic |
| WO2016145628A1 (en) * | 2015-03-18 | 2016-09-22 | Nestec S.A. | Composition comprising siallyllactose for use in enhancing learning skills and memory function |
| US10857167B2 (en) | 2015-04-28 | 2020-12-08 | Children's Hospital Medical Center | Use of oligosaccharide compositions to enhance weight gain |
| EP3331534B1 (en) * | 2015-08-04 | 2019-12-18 | Société des Produits Nestlé S.A. | Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants |
| CN108541221B (zh) | 2015-12-15 | 2023-02-28 | 格礼卡姆股份公司 | Hmo的混合物 |
| MX2018009016A (es) * | 2016-01-26 | 2018-09-28 | Nestec Sa | Composiciones que comprenden oligosacaridos sialilados para usar en infantes o niños pequeños para prevenir la obesidad mas adelante en la vida o comorbilidades relacionadas y promover un crecimiento sano. |
| EP3407740A1 (en) * | 2016-01-26 | 2018-12-05 | Nestec S.A. | COMPOSITIONS COMPRISING 2FL AND LNnT TO CONTROL FOOD INTAKE AND GROWTH IN INFANTS OR YOUNG CHILDREN |
| JP7088829B2 (ja) * | 2016-04-13 | 2022-06-21 | 株式会社明治 | 新生児向けの脳機能改善用組成物 |
| CA3030809A1 (en) | 2016-07-28 | 2018-02-01 | Fonterra Co-Operative Group Limited | Sialyloligosaccharide product and process |
| MX2019010742A (es) | 2017-05-04 | 2020-02-13 | Univ Leland Stanford Junior | Composiciones de alimento y kits promotoras del neurodesarrollo, sistemas y metodos relacionados con las mismas. |
| AU2018269462B2 (en) | 2017-05-16 | 2024-04-18 | Ability Pharmaceuticals S.L. | A pharmaceutical combination for the treatment of a cancer |
| CN110573030A (zh) * | 2017-05-24 | 2019-12-13 | 雀巢产品有限公司 | 用于增强注意力和/或降低冲动的营养组合物 |
| EP3648617A1 (en) * | 2017-07-07 | 2020-05-13 | Société des Produits Nestlé S.A. | Human milk fortifier |
| US12628859B2 (en) | 2017-07-07 | 2026-05-19 | Societe Des Produits Nestle S.A. | Human milk fortifier |
| RU2698564C1 (ru) * | 2019-01-09 | 2019-08-28 | Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) | Способ прогнозирования риска развития гипотрофии у детей, родившихся в сроке сверхранних преждевременных родов, к скорригированному возрасту 6 месяцев |
| MX2023005669A (es) | 2020-12-04 | 2023-05-26 | Nestle Sa | Composicion acuosa estable para promover el crecimiento posnatal temprano en infantes prematuros. |
| KR102570073B1 (ko) * | 2022-11-17 | 2023-08-24 | (주)에이피테크놀로지 | 2'-푸코실락토오스를 포함하는 치매 개선 또는 치료용조성물 |
| CN118285505A (zh) * | 2024-03-29 | 2024-07-05 | 黑龙江飞鹤乳业有限公司 | 促进大脑发育的营养组合物、食品及配方奶粉 |
| WO2025257135A1 (en) | 2024-06-10 | 2025-12-18 | N.V. Nutricia | Non-digestible oligosaccharide mixture for infants at risk of brain injury |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991016449A1 (en) | 1990-04-16 | 1991-10-31 | The Trustees Of The University Of Pennsylvania | Saccharide compositions, methods and apparatus for their synthesis |
| US5545553A (en) | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| US20040048926A1 (en) * | 2002-03-15 | 2004-03-11 | Hoffman Dennis Robert | Use of docosahexaenoic acid and arachidonic acid to enhance the visual development of term infants breast-fed up to the age of six months |
| WO2004112507A1 (en) * | 2003-06-23 | 2004-12-29 | Nestec S.A. | Infant or follow-on formula |
| CN1863463B (zh) * | 2003-06-23 | 2011-05-04 | 雀巢技术公司 | 用于促进肠道屏障成熟的营养组合物 |
| PL1644482T5 (pl) * | 2003-06-30 | 2015-05-29 | Clasado Inc | Nowa kompozycja galaktooligosacharydów i jej wytwarzanie |
| US20070166411A1 (en) * | 2005-12-16 | 2007-07-19 | Bristol-Myers Squibb Company | Nutritional supplement containing long-chain polyunsaturated fatty acids |
| WO2007090894A1 (en) * | 2006-02-10 | 2007-08-16 | Nestec S.A. | Oligosaccharide mixture |
| US9005682B2 (en) * | 2006-03-07 | 2015-04-14 | Nestec S.A. | Synbiotic mixture |
| US20080003330A1 (en) | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Infant formulas for early brain development |
| CN103005453B (zh) * | 2007-11-26 | 2015-08-19 | 雀巢产品技术援助有限公司 | 按年龄配制的婴儿营养系统 |
| EP2417144B1 (en) * | 2009-04-07 | 2017-08-23 | Glycom A/S | Synthesis of 2'-o-fucosyllactose |
| EP2251030A1 (en) | 2009-05-12 | 2010-11-17 | Nestec S.A. | Lactoferrin and brain health and development in infants |
| EP2258216A1 (en) * | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
| EP2258218A1 (en) | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
| EP2459202A1 (en) * | 2009-07-31 | 2012-06-06 | Nestec S.A. | Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients |
| US8993740B2 (en) * | 2010-02-19 | 2015-03-31 | Glycom A/S | Method for preparation of the tetrasaccharide lacto-N-neotetraose (LNnt) containing N-acetyllactosamine |
| EP2404507A1 (en) | 2010-07-08 | 2012-01-11 | Nestec S.A. | Array of age-tailored nutritional formula with optimum fat content |
| BR112013031086A2 (pt) * | 2011-06-08 | 2016-11-29 | Nestec Sa | composições nutricionais tendo componentes de membrana de glóbulo de gordura de leite exógenos |
-
2012
- 2012-10-12 MY MYPI2014700417A patent/MY170185A/en unknown
- 2012-10-12 WO PCT/EP2012/070281 patent/WO2013057049A1/en not_active Ceased
- 2012-10-12 US US14/352,236 patent/US20140271562A1/en not_active Abandoned
- 2012-10-12 PL PL12772784T patent/PL2775852T3/pl unknown
- 2012-10-12 EP EP16174616.9A patent/EP3095331A1/en not_active Withdrawn
- 2012-10-12 RU RU2014119844A patent/RU2607458C2/ru active
- 2012-10-12 BR BR112014008944-2A patent/BR112014008944B1/pt active IP Right Grant
- 2012-10-12 PT PT127727840T patent/PT2775852T/pt unknown
- 2012-10-12 MX MX2014004716A patent/MX350435B/es active IP Right Grant
- 2012-10-12 AU AU2012325060A patent/AU2012325060B2/en not_active Withdrawn - After Issue
- 2012-10-12 ES ES12772784.0T patent/ES2601891T3/es active Active
- 2012-10-12 EP EP12772784.0A patent/EP2775852B1/en active Active
- 2012-10-12 CN CN201280051291.6A patent/CN103889238B/zh active Active
- 2012-10-12 IN IN1468DEN2014 patent/IN2014DN01468A/en unknown
- 2012-10-12 PH PH1/2014/500443A patent/PH12014500443A1/en unknown
-
2014
- 2014-03-27 CL CL2014000759A patent/CL2014000759A1/es unknown
- 2014-05-16 ZA ZA2014/03591A patent/ZA201403591B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX350435B (es) | 2017-09-06 |
| WO2013057049A1 (en) | 2013-04-25 |
| CN103889238B (zh) | 2017-10-13 |
| CN103889238A (zh) | 2014-06-25 |
| PL2775852T3 (pl) | 2017-02-28 |
| CL2014000759A1 (es) | 2014-08-22 |
| BR112014008944B1 (pt) | 2020-09-15 |
| PT2775852T (pt) | 2016-11-08 |
| ES2601891T3 (es) | 2017-02-16 |
| RU2607458C2 (ru) | 2017-01-10 |
| IN2014DN01468A (enExample) | 2015-05-22 |
| AU2012325060A1 (en) | 2014-03-13 |
| EP3095331A1 (en) | 2016-11-23 |
| MX2014004716A (es) | 2015-02-05 |
| BR112014008944A2 (pt) | 2017-05-02 |
| EP2775852B1 (en) | 2016-08-17 |
| US20140271562A1 (en) | 2014-09-18 |
| ZA201403591B (en) | 2016-01-27 |
| EP2775852A1 (en) | 2014-09-17 |
| PH12014500443A1 (en) | 2014-04-14 |
| AU2012325060B2 (en) | 2015-11-19 |
| RU2014119844A (ru) | 2015-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12014500443A1 (en) | Composition for use in brain growth and/or cognitive and/or psychomotor development | |
| MY173726A (en) | Synbiotics combination for brain improvement | |
| PH12014500509B1 (en) | Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery | |
| PH12014500558A1 (en) | Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease | |
| PH12012501823A1 (en) | Infant nutrition for improving fatty acid composition of brain membranes | |
| PH12013502105A1 (en) | Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof | |
| PH12017500387A1 (en) | Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition | |
| PH12014500075A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
| PH12014500453A1 (en) | Composition for use in increasing insulin sensitivity and/or reducing insulin resistance | |
| IN2015DN00924A (enExample) | ||
| BR112015013349A2 (pt) | trieptanoína para o tratamento de deficiência de transportador de glicose 1 | |
| PH12018500035A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
| PH12015501334A1 (en) | Milk-based nutritional compositions containing lactoferrin and uses thereof | |
| BR112012023328A2 (pt) | composições nutricionais | |
| PH12014500344A1 (en) | Composition for use in the promotion of magnesium absorption and/or magnesium retention | |
| WO2014194053A3 (en) | Carbohydrate compounds for nutritional and therapeutic use | |
| NZ626540A (en) | Glutamine enriched nutritional composition for preterm infants | |
| HK1201067A1 (en) | Sialic acid analogs | |
| PH12014501569A1 (en) | Glutamine enriched nutritional composition for preterm infants | |
| NZ709741A (en) | Improvement of cognitive function in preterm infants that are small for gestational age | |
| MX2012012324A (es) | Formulaciones y usos del derivado del acido 2 - hidroxi -5 - fenilazobenzoico para el tratamiento de varones. | |
| UA52520U (ru) | Способ лечения нарушений функционального состояния кишечника у новорожденных и детей младенческого возраста | |
| PL401911A1 (pl) | Zastosowanie preparatu o wlasciwosciach immunoregulatorowych | |
| UA94869C2 (ru) | Применение липофлавона в качестве средства для лечения острой черепно-мозговой травмы | |
| UA65038U (ru) | Способ лечения больных послеродовыми психозами |